메뉴 건너뛰기




Volumn 49, Issue 4, 2002, Pages 701-702

In vitro antimicrobial susceptibility of clinical isolates of Aeromonas caviae, Aeromonas hydrophila and Aeromonas veronii biotype sobria [3]

Author keywords

[No Author keywords available]

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE ANTIBIOTIC AGENT; AMOXICILLIN PLUS CLAVULANIC ACID; AMPICILLIN; ANTIBIOTIC AGENT; AZTREONAM; BETA LACTAM ANTIBIOTIC; CEFAZOLIN; CEFEPIME; CEFIXIME; CEFOTAXIME; CEFTAZIDIME; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; CIPROFLOXACIN; COTRIMOXAZOLE; FOSFOMYCIN; GENTAMICIN; IMIPENEM; NALIDIXIC ACID; NITROFURANTOIN; OFLOXACIN; PIPEMIDIC ACID; PIPERACILLIN; PIPERACILLIN PLUS TAZOBACTAM; TICARCILLIN; TOBRAMYCIN;

EID: 0036233456     PISSN: 03057453     EISSN: None     Source Type: Journal    
DOI: 10.1093/jac/49.4.701     Document Type: Letter
Times cited : (87)

References (7)
  • 3
    • 0037721186 scopus 로고    scopus 로고
    • Performance Standards for Antimicrobial Susceptibility Testing. Eleventh Informational Supplement M100-S11
    • National Committee for Clinical Laboratory Standards. NCCLS, Wayne, PA
    • (2001)


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.